News Amgen/UCB's osteoporosis drug hit by cardio risk Competitor to Amgen's Epogen also moves closer to market
News Amgen/UCB reveal new osteoporosis drug data But romosozumab missed secondary endpoint of non-vertebral fractures
News Amgen's Prolia succeeds in glucocorticoid-induced osteoporos... Possible new use for well-established drug.
Articles UCB: growing sales and growing bones The specialist pharma company is set to expand into osteoporosis through its partnership with Amgen